Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023

Rhea-AI Summary

Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular interventions, will release its Q1 2023 financial results on May 9, 2023, before U.S. markets open. A conference call is scheduled for the same day at 10 a.m. EST to discuss the results and corporate updates. Investors can access the call by dialing 800-715-9871 (US) or 1-646-307-1963 (International), using pass code 8054202. A replay of the call will be available for one month after the live event. Stereotaxis aims to enhance patient care through its robotic solutions, having served over 100,000 patients across various regions. This announcement emphasizes the company's commitment to transparency and engagement with its shareholders, as it prepares to disclose vital financial information.

Positive

• Scheduled Q1 2023 financial results release on May 9, 2023, indicating commitment to transparency.
• Company to hold a conference call, showcasing active engagement with investors.

Negative

• None.

ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 first quarter on Tuesday, May 9, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:		Stereotaxis first quarter 2023 financial results conference call
When:		Tuesday, May 9, 2023, at 10:00 a.m. EST (7:00 a.m. PST)
Dial In Number:		To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 8054202.
Webcast:		To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.
Call Replay:		A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
Investors@Stereotaxis.com

FAQ

When will Stereotaxis release its Q1 2023 financial results?

Stereotaxis will release its Q1 2023 financial results on May 9, 2023, before the U.S. markets open.

What time is the conference call for Stereotaxis' Q1 financial results?

The conference call will be held at 10 a.m. EST on May 9, 2023.

How can I access Stereotaxis' financial results conference call?

You can access the call by dialing 800-715-9871 (US) or 1-646-307-1963 (International) and entering pass code 8054202.

Where can I find the replay of Stereotaxis' Q1 2023 financial results call?

The replay of the call will be available for one month following the live event.